2026 NIAID DMID Omnibus Broad Agency Announcement

This Broad Agency Announcement (BAA) HHS-NIH-NIAID-BAA2025-1 solicits basic and applied research proposals for advancing the state-of-the-art in areas related to infectious diseases, specifically focusing on Research Areas 001 (Development of Candidate Therapeutics, Vaccines, and In Vitro Diagnostics for Antimicrobial-Resistant (AMR) Bacterial or Fungal Pathogens) and 002 (Development of Direct Acting Antivirals (DAA) for Viral Families of Pandemic Potential). Offerors may submit proposals to one or both Research Areas, responding to Topics A, B, and/or C within Research Area 001. Proposals must include detailed technical and business plans tailored to the specific objectives of each proposed Research Area and/or Topic. Key requirements include a comprehensive subcontracting plan with goals for Small, Small Disadvantaged, Women-Owned, HUBZone, Veteran-Owned, and Service-Disabled Veteran-Owned Small Business concerns, a detailed Work Plan outlining project phases and timelines, and a Total Compensation Plan demonstrating a clear understanding of personnel requirements and realistic compensation structures. Additionally, proposals for clinical research must address plans for inclusion of women and minorities, and justification for any exclusions, particularly regarding children, including expertise and facility suitability if children are included.

Notice ID

44a2b2c9f0c04ba09a1365281b912b1b

Solicitation Number

HHS-NIH-NIAID-BAA2025-1

NAICS Code

541715

Classification Code

AN12